Advertisement
Research Article Free access | 10.1172/JCI118893
Department of Pediatrics, University Hospital Nijmegen, The Netherlands.
Find articles by Lemmink, H. in: JCI | PubMed | Google Scholar
Department of Pediatrics, University Hospital Nijmegen, The Netherlands.
Find articles by Nillesen, W. in: JCI | PubMed | Google Scholar
Department of Pediatrics, University Hospital Nijmegen, The Netherlands.
Find articles by Mochizuki, T. in: JCI | PubMed | Google Scholar
Department of Pediatrics, University Hospital Nijmegen, The Netherlands.
Find articles by Schröder, C. in: JCI | PubMed | Google Scholar
Department of Pediatrics, University Hospital Nijmegen, The Netherlands.
Find articles by Brunner, H. in: JCI | PubMed | Google Scholar
Department of Pediatrics, University Hospital Nijmegen, The Netherlands.
Find articles by van Oost, B. in: JCI | PubMed | Google Scholar
Department of Pediatrics, University Hospital Nijmegen, The Netherlands.
Find articles by Monnens, L. in: JCI | PubMed | Google Scholar
Department of Pediatrics, University Hospital Nijmegen, The Netherlands.
Find articles by Smeets, H. in: JCI | PubMed | Google Scholar
Published September 1, 1996 - More info
Benign familial hematuria (BFH) is characterized by autosomal dominant inheritance, thinning of the glomerular basement membrane (GBM) and normal renal function. It is frequent in patients with persistent microscopic hematuria, but cannot be clinically differentiated from the initial stages of Alport syndrome, a severe GBM disorder which progresses to renal failure. We present here linkage of benign familial hematuria with the COL4A3 and COL4A4 genes at 2q35-37 (Zmax = 3.58 at theta = 0.0). Subsequently, a glycine to glutamic acid substitution was identified in the collagenous region of the COL4A4 gene. We conclude that type IV collagen defects cause both benign hematuria and Alport syndrome. Furthermore, our data suggest that BFH patients can be carriers of autosomal recessive Alport syndrome.